New blood test offers early detection of drug-induced tissue damage in cancer patients
A new study introduces a simple blood test to detect early lung damage in cancer…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Study identifies new approach to overcome docetaxel resistance in patients with advanced prostate cancer
The treatment landscape for patients with prostate cancer, especially individuals with advanced disease, has dramatically…
Glioblastoma: new treatment targets brain tumours from multiple angles
Glioblastoma is the most common kind of malignant brain tumour in adults. So far, no…
New study links air pollution with higher rates of head and neck cancer
A recent study published in the journal Scientific Reports correlates higher levels of pollutant particulate matter to…
Immunotherapy drug pembrolizumab improves outcomes for patients with soft tissue sarcoma
The addition of the immunotherapy drug pembrolizumab to the standard of care for patients with…
Combination approach shows promise for treating rare, aggressive cancers
A research team led by UCLA Health Jonsson Comprehensive Cancer Centre investigators has shown that combining…
Better chances for chemotherapy in neuroblastoma
Blocking the METTL3 protein can increase sensitivity to chemotherapy in neuroblastoma, according to research from…
Persistent overtreatment of prostate cancer in men with limited life expectancy
A recent study in JAMA Internal Medicine sheds light on persistent overtreatment of prostate cancer…
Using CRISPR to decipher whether gene variants lead to cancer
In recent years, scientists have created a range of new methods based on CRISPR-Cas technology…
Study finds traditional open surgery for lymph node removal remains gold standard for testicular cancer
Although much rarer than either breast or prostate cancers, testicular cancer is the most common…